Crossmark

SKP2 promotes breast cancer tumorigenesis and radiation tolerance through PDCD4 ubiquitination

Crossref DOI link: https://doi.org/10.1186/s13046-019-1069-3

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Ce

Du, Lutao

Ren, Yidan

Liu, Xiaoyan

Jiao, Qinlian

Cui, Donghai

Wen, Mingxin

Wang, Chuanxin

Wei, Guangwei

Wang, Yunshan

Ji, Aiguo

Wang, Qin
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81874040)

National Natural Science Foundation of China (81500029)

National Natural Science Foundation of China (81371455)

Natural Science Foundation of Shandong Province (BS2015YY05)
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 16 November 2018

Accepted: 30 January 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: The institutional review board of QiLu hospital had approved the study by using formalin-fixed tissue. The Institutional Animal Care and Use Committee (IACUC) was from Ethics Committee of Qilu Hospital of Shandong University.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.